KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Other Non-Current Assets (2020 - 2025)

Ginkgo Bioworks Holdings' Other Non-Current Assets history spans 6 years, with the latest figure at $47.2 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 14.76% year-over-year to $47.2 million; the TTM value through Dec 2025 reached $47.2 million, down 14.76%, while the annual FY2025 figure was $47.2 million, 14.76% down from the prior year.
  • Other Non-Current Assets reached $47.2 million in Q4 2025 per DNA's latest filing, up from $46.6 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $97.9 million in Q2 2023 to a low of $26.8 million in Q3 2021.
  • Average Other Non-Current Assets over 5 years is $60.9 million, with a median of $55.3 million recorded in 2024.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 120.87% in 2023, then plummeted 38.53% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $26.8 million in 2021, then skyrocketed by 231.05% to $88.7 million in 2022, then crashed by 34.57% to $58.1 million in 2023, then fell by 4.68% to $55.3 million in 2024, then dropped by 14.76% to $47.2 million in 2025.
  • Per Business Quant, the three most recent readings for DNA's Other Non-Current Assets are $47.2 million (Q4 2025), $46.6 million (Q3 2025), and $47.0 million (Q2 2025).